In Reply to the Letter to Editor Regarding "discrepancy Between WGS-based Genotypic and Phenotypic Drug Susceptibility Testing of First and Second-Line Drugs for Mycobacterium Tuberculosis: Limited Impact of Unknown Resistance Mechanisms".